“Risk of Arterial and Venous Thromboembolic Events With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis”. Global Journal of Medical Research 20, no. B1 (February 22, 2020): 71–85. Accessed August 13, 2026. https://medicalresearchjournal.org/index.php/GJMR/article/view/1952.